Jodi Ph.D.
Head of Patient Advocacy, U.S. at Santhera Pharmaceuticals - Pratteln, Basel-Landschaft, CH
Jodi Ph.D.'s Colleagues at Santhera Pharmaceuticals
Jodi Ph.D.'s Contact Details
+41 61 906 89 50
Santhera Pharmaceuticals
Jodi Ph.D.'s Company Details
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need. The Company has an exclusive license from ReveraGen for all indications worldwide to AGAMREE® (vamorolone), a dissociative steroid with novel mode of action, which was investigated in a pivotal study in patients with Duchenne muscular dystrophy (DMD) as an alternative to standard corticosteroids. AGAMREE for the treatment of DMD is approved in the U.S. by the Food and Drug Administration (FDA), in the EU by the European Medicines Agency (EMA), and in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA). Santhera has out-licensed rights to AGAMREE for North America to Catalyst Pharmaceuticals, Inc. and for China to Sperogenix Therapeutics. For more information, please visit the Company's website at www.santhera.com